Authors:
JERUSALEM G
BEGUIN Y
FASSOTTE MF
NAJJAR F
PAULUS P
RIGO R
FILLET G
Citation: G. Jerusalem et al., EARLY ASSESSMENT OF RESPONSE TO CHEMOTHERAPY BY FDG-PET IS HIGHLY PREDICTIVE OF OUTCOME IN PATIENTS WITH HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), European journal of cancer, 34, 1998, pp. 120-120
Authors:
JERUSALEM G
BEGUIN Y
FASSOTTE MF
NAJJAR F
PAULUS P
RIGO P
FILLET G
Citation: G. Jerusalem et al., WHOLE-BODY FDG-PET FOR POST TREATMENT EVALUATION IN HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL) HAS HIGHER DIAGNOSTIC AND PROGNOSTIC VALUE THAN CLASSICAL CT SCAN IMAGING, European journal of cancer, 34, 1998, pp. 121-121
Authors:
HUSTINX R
PAULUS P
JACQUET N
JERUSALEM G
BURY T
RIGO P
Citation: R. Hustinx et al., CLINICAL-EVALUATION OF WHOLE-BODY F-18 FLUORDEOXYGLUCOSE POSITRON-EMISSION-TOMOGRAPHY IN THE DETECTION OF LIVER METASTASES, Annals of oncology, 9(4), 1998, pp. 397-401
Authors:
FRAIPONT V
SAUTOIS B
BAUDOUX E
FASSOTTE MF
JERUSALEM G
HERMANNE JP
LONGREE L
SONDAG D
FILLET G
BEGUIN Y
Citation: V. Fraipont et al., EFFICIENT MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) WITH G-CSF ALONE IN PATIENTS FAILING TO REACH ADEQUATE NUMBERS OF CD34(-GM WITH CHEMOTHERAPY AND G-CSF() CELLS OR CFU), Bone marrow transplantation, 21, 1998, pp. 371-371
Authors:
JERUSALEM G
NAJJAR F
PAULUS P
BEGUIN Y
FASSOTTE MF
FILLET G
RIGO P
Citation: G. Jerusalem et al., EARLY ASSESSMENT OF RESPONSE TO CHEMOTHERAPY BY FDG-PET IS HIGHLY PREDICTIVE OF OUTCOME IN PATIENTS WITH HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), The Journal of nuclear medicine, 39(5), 1998, pp. 580-580
Authors:
JERUSALEM G
NAJJAR F
BEGUIN Y
PAULUS P
FASSOTTE MF
FILLET G
RIGO P
Citation: G. Jerusalem et al., FDG-PET FOR POST-TREAMENT EVALUATION IN HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL) HAS HIGHER DIAGNOSTIC AND PROGNOSTIC VALUE THAN CT IMAGING, The Journal of nuclear medicine, 39(5), 1998, pp. 1116-1116
Authors:
FRAIPONT V
SAUTOIS B
BAUDOUX E
FASSOTTE MF
JERUSALEM G
HERMANNE JP
LONGREE L
SCHAAFLAFONTAINE N
SONDAG D
FILLET G
BEGUIN Y
Citation: V. Fraipont et al., PBPC MOBILIZATION WITH G-CSF ALONE IN PATIENTS FAILING WITH CHEMOTHERAPY AND G-CSF, British Journal of Haematology, 102(1), 1998, pp. 70-70
Authors:
JERUSALEM G
BEGUIN Y
FASSOTTE MF
NAJJAR F
PAULUS P
RIGO P
FILLET G
Citation: G. Jerusalem et al., WHOLE-BODY FDG-PET POSTTREATMENT EVALUATION IN HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL) HAS HIGHER DIAGNOSTIC AND PROGNOSTIC VALUE THAN CLASSICAL CT SCAN IMAGING, Blood, 90(10), 1997, pp. 1498-1498
Authors:
JERUSALEM G
BEGUIN Y
FASSOTTE MF
NAJJAR F
PAULUS P
RIGO P
FILLET G
Citation: G. Jerusalem et al., EARLY ASSESSMENT OF RESPONSE CHEMOTHERAPY BY FDG-PET IS HIGHLY PREDICTIVE OF OUTCOME IN PATIENTS WITH HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 1728-1728
Authors:
RIGO P
PAULUS P
KASCHTEN BJ
HUSTINX R
BURY T
JERUSALEM G
BENOIT T
FOIDARTWILLEMS J
Citation: P. Rigo et al., ONCOLOGICAL APPLICATIONS OF POSITRON EMISSION TOMOGRAPHY WITH F-18 FLUORODEOXYGLUCOSE, European journal of nuclear medicine, 23(12), 1996, pp. 1641-1674
Authors:
SAUTOIS B
FRAIPONT V
BAUDOUX E
FASSOTTE MF
JERUSALEM G
HERMANNE JP
BOURS V
BOSQUET L
PAULUS JM
SONDAG D
FILLET G
BEGUIN Y
Citation: B. Sautois et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN CANCER-PATIENTS - ANALYSIS OF FACTORS AFFECTING THE COLLECTIONS YIELDS, Blood, 88(10), 1996, pp. 3693-3693
Authors:
JERUSALEM G
FASSOTTE MF
PAULUS P
RIGO P
FILLET G
Citation: G. Jerusalem et al., WHOLE-BODY POSITRON EMISSION TOMOGRAPHY (PET) FOR STAGING, RESPONSE EVALUATION AND FOLLOW-UP OF HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 86(10), 1995, pp. 2125-2125